M.R. Clemens

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

Michael Herold, R. Pasold, Stefanie Srock et al. · Blood · 2004 · 72 citations

Medicine, Oncology, Pharmacotherapy +13

Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)

Axel Grothey, T. Buechele, Hendrik Kroening et al. · European Journal of Cancer · 2001 · 57 citations

Medicine, Oncology, Pharmacotherapy +16

Prospective Randomized Trial of Dichloromethylene Bisphosphonate (Clodronate) in Patients with Multiple Myeloma Requiring Treatment. A Multicenter Study

Manfred Heim, M.R. Clemens, W. Queißer et al. · Onkologie · 2009 · 52 citations

Medicine, Pharmacology, Pharmacotherapy +15

Six versus eight cycles of biweekly CHOP-14 with or without R in elderly patients (pts) with aggressive CD20⁺ B-cell lymphomas: Seven-year FU of the RICOVER-60 trial of the DSHNHL.

Michael Pfreundschuh, Marita Ziepert, Samira Zeynalova et al. · Journal of Clinical Oncology · 2011 · 48 citations

Medicine, Oncology, Aging +4

Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.

Carsten Bokemeyer, J. T. Hartmann, Christine S Lampe et al. · PubMed · 1997 · 29 citations

Medicine, Oncology, Pharmacology +15